Cargando…
Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy
BACKGROUND: The purpose of this study was to evaluate nepafenac ophthalmic suspension 0.1% (Nevanac(®); Alcon Research Ltd) in the prevention of macular edema following cataract surgery in diabetic retinopathy patients. METHODS: This was a multicenter, randomized, double-masked, vehicle-controlled s...
Autores principales: | Singh, Rishi, Alpern, Louis, Jaffe, Glenn J, Lehmann, Robert P, Lim, John, Reiser, Harvey J, Sall, Kenneth, Walters, Thomas, Sager, Dana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422154/ https://www.ncbi.nlm.nih.gov/pubmed/22927737 http://dx.doi.org/10.2147/OPTH.S31902 |
Ejemplares similares
-
Effect of topical nepafenac in prevention of macular edema after cataract surgery in patients with non-proliferative diabetic retinopathy
por: Sarfraz, Muhammad Haroon, et al.
Publicado: (2017) -
Topical nepafenac in the treatment of diabetic macular edema
por: Callanan, David, et al.
Publicado: (2008) -
Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives
por: Yüksel, Bora, et al.
Publicado: (2017) -
Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac
por: Aaronson, Alexander, et al.
Publicado: (2020) -
Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
por: Singh, Rishi P, et al.
Publicado: (2017)